BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1981104)

  • 1. Which agent and how to deliver it? A review of benzodiazepine sedation and its reversal in endoscopy.
    McCloy RF; Pearson RC
    Scand J Gastroenterol Suppl; 1990; 179():7-11. PubMed ID: 1981104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flumazenil in children after esophagogastroduodenoscopy.
    Peters JM; Tolia V; Simpson P; Aravind MK; Kauffman RE
    Am J Gastroenterol; 1999 Jul; 94(7):1857-61. PubMed ID: 10406248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of central benzodiazepine effects by flumazenil after conscious sedation produced by intravenous diazepam. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):895-909. PubMed ID: 1286497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopist administered sedation during ERCP: impact of chronic narcotic/benzodiazepine use and predictive risk of reversal agent utilization.
    Papachristou GI; Gleeson FC; Papachristou DJ; Petersen BT; Baron TH
    Am J Gastroenterol; 2007 Apr; 102(4):738-43. PubMed ID: 17324132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of central benzodiazepine effects by intravenous flumazenil after conscious sedation with midazolam and opioids: a multicenter clinical study. The Flumazenil in Intravenous Conscious Sedation with Midazolam Multicenter Study Group II.
    Clin Ther; 1992; 14(6):878-94. PubMed ID: 1286496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of sedation agents and reversal agents.
    Fassoulaki A; Theodoraki K; Melemeni A
    Digestion; 2010; 82(2):80-3. PubMed ID: 20407249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine reversal with flumazenil--a review of the literature.
    Piekarski JM; Rossmann JA; Putman J
    J Can Dent Assoc; 1992 Apr; 58(4):307-10. PubMed ID: 1350501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of central nervous system effects by flumazenil after intravenous conscious sedation with midazolam: report of a multicenter clinical study. The Flumazenil in Intravenous Conscious Sedation with Midazolam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):861-77. PubMed ID: 1286495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reversal of midazolam sedation with the benzodiazepine antagonist flumazenil (Anexate).
    Merry AF; Clapham GJ; Walker JS
    N Z Med J; 1988 Sep; 101(853):571-2. PubMed ID: 3138580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of intravenous midazolam and diazepam used as sedative agents in upper digestive endoscopy].
    Mignonsin D; Kouame K; Camara B; Bondurand M
    Cah Anesthesiol; 1994; 42(1):25-30. PubMed ID: 8076229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy.
    Kankaria A; Lewis JH; Ginsberg G; Gallagher J; al-Kawas FH; Nguyen CC; Fleischer DE; Benjamin SB
    Gastrointest Endosc; 1996 Oct; 44(4):416-21. PubMed ID: 8905360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing and side effects of flumazenil for dental outpatients receiving intravenous sedation with midazolam.
    Misaki T; Kyoda N; Oka S; Takada K; Kunimatu T; Tajima A
    Anesth Prog; 1997; 44(4):127-31. PubMed ID: 9481956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sedation and analgesia during gastrointestinal endoscopy].
    Müllner K; Tulassay Z
    Orv Hetil; 2011 Mar; 152(11):428-36. PubMed ID: 21362603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability to reverse deeper levels of unintended sedation.
    Morse J; Bamias G
    Digestion; 2010; 82(2):94-6. PubMed ID: 20407253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta activation following the intravenous administration of benzodiazepines and the specific antagonist flumazenil (Ro 15-1788)].
    Suttmann H; Rampf U; Juhl G; Greim M; Doenicke A
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1990 Mar; 21(1):20-8. PubMed ID: 1970957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the sedation and recovery profiles of Ro 48-6791, a new benzodiazepine, and midazolam in combination with meperidine for outpatient endoscopic procedures.
    Tang J; Wang B; White PF; Gold M; Gold J
    Anesth Analg; 1999 Oct; 89(4):893-8. PubMed ID: 10512261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sedation in endoscopic diagnosis: rationale of the use of specific benzodiazepine antagonists].
    Chillemi S; Milici M; De Francesco F; Buda CA; Maisano C; Minutoli N; Querci A; Lemma F
    G Chir; 1996; 17(6-7):349-52. PubMed ID: 9272978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sedation in quail induced by use of midazolam and reversed by use of flumazenil.
    Day TK; Roge CK
    J Am Vet Med Assoc; 1996 Sep; 209(5):969-71. PubMed ID: 8790552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, prospective, double-blind comparison of midazolam (Versed) and emulsified diazepam (Dizac) for opioid-based, conscious sedation in endoscopic procedures.
    Van Houten JS; Crane SA; Janardan SK; Wells K
    Am J Gastroenterol; 1998 Feb; 93(2):170-4. PubMed ID: 9468235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.